J&J denies class action’s claims that it sold ineffective cold meds
Class Actions 2025-10-01 11:45 pm By Cindy Cameronne | Sydney
Please login to bookmark Close

Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au